SeraNovo receives ELF Pre-seed loan

SeraNovo has acquired a € 30.000 loan from ELF Pre-seed to develop their drug formulation platform.

This startup has solved the problem that most drugs currently in development perform poorly due to problems with either solubility, permeability or both when taken as an oral pill. The loan will be used to develop the second phase of the technology with a view to creating a market ready service with and ultimately a product line in the coming years.

SeraNovo was founded by Niall Hodgins (CEO) and Bastiaan Kluft (CSO).